Literature DB >> 21547550

Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors.

Sree Kanth Sivan1, Vijjulatha Manga.   

Abstract

Multiple receptors conformation docking (MRCD) and clustering of dock poses allows seamless incorporation of receptor binding conformation of the molecules on wide range of ligands with varied structural scaffold. The accuracy of the approach was tested on a set of 120 cyclic urea molecules having HIV-1 protease inhibitory activity using 12 high resolution X-ray crystal structures and one NMR resolved conformation of HIV-1 protease extracted from protein data bank. A cross validation was performed on 25 non-cyclic urea HIV-1 protease inhibitor having varied structures. The comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) models were generated using 60 molecules in the training set by applying leave one out cross validation method, r (loo) (2) values of 0.598 and 0.674 for CoMFA and CoMSIA respectively and non-cross validated regression coefficient r(2) values of 0.983 and 0.985 were obtained for CoMFA and CoMSIA respectively. The predictive ability of these models was determined using a test set of 60 cyclic urea molecules that gave predictive correlation (r (pred) (2) ) of 0.684 and 0.64 respectively for CoMFA and CoMSIA indicating good internal predictive ability. Based on this information 25 non-cyclic urea molecules were taken as a test set to check the external predictive ability of these models. This gave remarkable out come with r (pred) (2) of 0.61 and 0.53 for CoMFA and CoMSIA respectively. The results invariably show that this method is useful for performing 3D QSAR analysis on molecules having different structural motifs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547550     DOI: 10.1007/s00894-011-1048-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  34 in total

1.  Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.

Authors:  W Sippl
Journal:  J Comput Aided Mol Des       Date:  2000-08       Impact factor: 3.686

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

Review 3.  HIV protease: a novel chemotherapeutic target for AIDS.

Authors:  J R Huff
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

Review 4.  The retroviral enzymes.

Authors:  R A Katz; A M Skalka
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

5.  Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.

Authors:  P K Jadhav; F J Woerner; P Y Lam; C N Hodge; C J Eyermann; H W Man; W F Daneker; L T Bacheler; M M Rayner; J L Meek; S Erickson-Viitanen; D A Jackson; J C Calabrese; M Schadt; C H Chang
Journal:  J Med Chem       Date:  1998-04-23       Impact factor: 7.446

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.

Authors:  P K Jadhav; P Ala; F J Woerner; C H Chang; S S Garber; E D Anton; L T Bacheler
Journal:  J Med Chem       Date:  1997-01-17       Impact factor: 7.446

8.  Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors.

Authors:  W Schaal; A Karlsson; G Ahlsén; J Lindberg; H O Andersson; U H Danielson; B Classon; T Unge; B Samuelsson; J Hultén; A Hallberg; A Karlén
Journal:  J Med Chem       Date:  2001-01-18       Impact factor: 7.446

9.  Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450.

Authors:  C N Hodge; P E Aldrich; L T Bacheler; C H Chang; C J Eyermann; S Garber; M Grubb; D A Jackson; P K Jadhav; B Korant; P Y Lam; M B Maurin; J L Meek; M J Otto; M M Rayner; C Reid; T R Sharpe; L Shum; D L Winslow; S Erickson-Viitanen
Journal:  Chem Biol       Date:  1996-04

10.  Receptor guided 3D-QSAR: a useful approach for designing of IGF-1R inhibitors.

Authors:  M Muddassar; F A Pasha; H W Chung; K H Yoo; C H Oh; S J Cho
Journal:  J Biomed Biotechnol       Date:  2008
View more
  1 in total

1.  Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening.

Authors:  Divya Yadav; Sarvesh Paliwal; Rakesh Yadav; Mahima Pal; Anubhuti Pandey
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.